get a key
steadybase-$ company SMTI
account_id none on file
legal_name Sanara MedTech Inc.
ticker SMTI
cik 714256
domain sanaramedtech.com
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
hq Fort Worth, TX, United States
calls 5 filings 0 executives 12 family 0
why_nownone on file
calls
Costs related to travel and in-person promotional activities increased by $0.9 million in 2022 compared to 2021 due to the resumption of many in-person activities that were canceled or postponed in 2021 as a result of the COVID-19 pandemic.

Mar 21, 2023 / receipt, needs a key / Mike McNeil, CFO | earnings call 2023-03-21 | transcript b3406bf8-bc5b-42cc-a8ba-e78030d7cf01 | chars 9509-9749 | segment 9

The higher direct sales and marketing expenses were primarily attributed to increase in sales volume Our sales commissions of 3.1 million as a result of higher product sales and 0.5 million of increased costs as a result of Salesforce expansion and 0.3 million of costs related to travel and operational support.

Nov 15, 2022 / receipt, needs a key / Mike McNeil, CFO | earnings call 2022-11-15 | transcript 35291029-627d-4ba3-a0f9-685ff6076b31 | chars 7069-7381 | segment 7

The increase in 2022 SG&A expenses was also partly attributable to increased non-cash equity compensation, higher travel and in-person promotional activity expenses, and higher payroll costs related to the mid-year addition of the Rochelle workforce in July 2021.

Aug 16, 2022 / receipt, needs a key / Mike McNeil, CFO | earnings call 2022-08-16 | transcript e9535719-3eb5-47d8-8b51-d50f27562894 | chars 8360-8623 | segment 8

In addition, the cost related to travel and in-person promotional activities increased in 2021 after those activities had been canceled or postponed in 2020 as a result of the COVID-19 pandemic.

Mar 31, 2022 / receipt, needs a key / Mike McNeil, CFO | earnings call 2022-03-31 | transcript 320f2031-72b1-44c3-96cc-2884cc83eb85 | chars 8628-8822 | segment 8

We're trying to figure out travel schedules. We're looking at conferences that we want to go to, et cetera. But we'll post that when we determine what our schedule is going to be and let you know in advance.

Mar 31, 2022 / receipt, needs a key / Ron Nixon, CEO | earnings call 2022-03-31 | transcript 320f2031-72b1-44c3-96cc-2884cc83eb85 | chars 15364-15571 | segment 16

filingsnone on file
executives
Elizabeth B. Taylor Chief Financial Officer - receipt
Eric Tanzberger director - receipt
Jacob A. Waldrop Chief Operating Officer - receipt
Keith Myers director - receipt
Mike McNeil CFO - receipt
Ron Nixon CEO - receipt
Ronald T. Nixon Chief Executive Officer - receipt
Roszell Mack III director - receipt
Sara Ortwein director - receipt
Seth D. Yon President and Chief Executive Officer - receipt
Zach Fleming CEO - receipt
Zachary B. Fleming Chief Executive Officer - receipt
familynone on file
upcoming
2026-11-11 earnings call scheduled ir
changes
2025-09-02 President and Chief Executive Officer, appointed sec_8k
2025-01-22 Chief Financial Officer, appointed sec_8k
2024-10-07 director, appointed sec_8k
2024-09-23 Chief Executive Officer, appointed sec_8k
2024-05-13 Chief Executive Officer, appointed sec_8k
2024-04-05 Chief Operating Officer, appointed sec_8k
2022-04-29 Chief Executive Officer, appointed sec_8k
2022-01-06 Chief Executive Officer, appointed sec_8k
2021-12-28 Chief Executive Officer, appointed sec_8k
2021-12-22 director, appointed sec_8k
2021-12-15 director, appointed sec_8k
2020-12-23 director, appointed sec_8k
mcp_package_hint
steadybase-$